These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Interferon therapy in chronic active viral hepatitis]. Lengyel G; Fehér J Orv Hetil; 1995 Jan; 136(1):3-7. PubMed ID: 7531317 [TBL] [Abstract][Full Text] [Related]
4. [Antiviral preparations in the therapy of chronic viral hepatitis]. Geller LI Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074 [TBL] [Abstract][Full Text] [Related]
6. [Immunomodulator therapy in chronic viral hepatitis]. Stanciu L Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):491-502. PubMed ID: 2484221 [No Abstract] [Full Text] [Related]
7. Antiviral agents in the treatment of chronic viral hepatitis. Perrillo RP Prog Liver Dis; 1992; 10():283-309. PubMed ID: 1284255 [No Abstract] [Full Text] [Related]
8. [Peripheral blood lymphocyte apoptosis in children with viral hepatites A, B, C and effect of ursodeoxycholic acid preparations]. Matanina NV; Reĭzis AR Eksp Klin Gastroenterol; 2008; (5):106-10. PubMed ID: 19145924 [TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic hepatitis. Lambiase L; Davis GL Gastroenterol Clin North Am; 1992 Sep; 21(3):659-77. PubMed ID: 1381338 [TBL] [Abstract][Full Text] [Related]
10. [Ursodeoxycholic hemisuccinate in the treatment of chronic active hepatitis. A controlled clinico-therapeutic study]. Buzzelli G; Moscarella S; Focardi G; Dattolo P; Giusti A; Calviani L; Relli P; Gentilini P Minerva Med; 1992 Sep; 83(9):537-40. PubMed ID: 1436604 [TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid after liver transplantation: does conjugation with taurine make the difference? Beuers U Ital J Gastroenterol Hepatol; 1999; 31(6):469-71. PubMed ID: 10575564 [No Abstract] [Full Text] [Related]
12. [Chronic hepatitis treated with alpha-interferon]. Michael M Orv Hetil; 1992 Jul; 133 Suppl 1():63-5. PubMed ID: 1630805 [TBL] [Abstract][Full Text] [Related]
13. From a choleretic to an immunomodulator: historical review of ursodeoxycholic acid as a medicament. Makino I; Tanaka H J Gastroenterol Hepatol; 1998 Jun; 13(6):659-64. PubMed ID: 9715413 [No Abstract] [Full Text] [Related]
14. [Current status of treatment for chronic viral hepatitis using recombinant interferon alpha]. Hopf U; Küther S; König V; Heuft HG; Berg T; Huhn D Dtsch Med Wochenschr; 1994 Jul; 119(27):961-4. PubMed ID: 8026311 [No Abstract] [Full Text] [Related]
15. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis. Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720 [TBL] [Abstract][Full Text] [Related]
17. [Positive effect of ursodeoxycholic acid on liver enzymes in autoimmune hepatitis with little activity--a pilot study]. Janowitz P; Kratzer W; Wechsler JG Leber Magen Darm; 1996 Nov; 26(6):310-3. PubMed ID: 9082112 [TBL] [Abstract][Full Text] [Related]
18. [Liver, biliary tracts and human immunodeficiency virus infection. 1:q liver, HIV and hepatitis B, C and D viruses]. Vuitton DA; Chossegros P; Bresson-Hadni S; Delfraissy JF; Kirn A; Marcellin P; Pol S; Saint-Paul MC Gastroenterol Clin Biol; 1996; 20(3):269-80. PubMed ID: 8763066 [No Abstract] [Full Text] [Related]
19. [Should chronic active viral hepatitis be treated with drugs or not?]. Schalm SW Internist (Berl); 1981 Dec; 22(12):717-20. PubMed ID: 7033161 [No Abstract] [Full Text] [Related]
20. [An etiopathogenic and therapeutic update in chronic viral hepatitis in children]. Moraru E Pediatrie (Bucur); 1992; 41(4):13-27. PubMed ID: 1335770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]